Insider Transactions in Q1 2023 at Bristol Myers Squibb CO (BMY)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 10
2023
|
Elizabeth Mily EVP, Strategy & BD |
SELL
Payment of exercise price or tax liability
|
Direct |
14,040
-15.65%
|
$912,600
$65.71 P/Share
|
|
Mar 10
2023
|
Elizabeth Mily EVP, Strategy & BD |
BUY
Other acquisition or disposition
|
Direct |
3,458
+3.59%
|
-
|
|
Mar 10
2023
|
Elizabeth Mily EVP, Strategy & BD |
BUY
Exercise of conversion of derivative security
|
Direct |
29,636
+24.79%
|
-
|
|
Mar 10
2023
|
Rupert Vessey EVP & President, Research |
SELL
Payment of exercise price or tax liability
|
Direct |
38,498
-9.55%
|
$2,502,370
$65.71 P/Share
|
|
Mar 10
2023
|
Rupert Vessey EVP & President, Research |
BUY
Other acquisition or disposition
|
Direct |
8,326
+2.03%
|
-
|
|
Mar 10
2023
|
Rupert Vessey EVP & President, Research |
BUY
Exercise of conversion of derivative security
|
Direct |
66,935
+13.8%
|
-
|
|
Mar 10
2023
|
Sandra Leung EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
34,104
-1.99%
|
$2,216,760
$65.71 P/Share
|
|
Mar 10
2023
|
Sandra Leung EVP, General Counsel |
BUY
Other acquisition or disposition
|
Direct |
8,731
+0.51%
|
-
|
|
Mar 10
2023
|
Sandra Leung EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
57,990
+3.2%
|
-
|
|
Mar 10
2023
|
Ann Powell EVP, Chief Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
16,810
-8.11%
|
$1,092,650
$65.71 P/Share
|
|
Mar 10
2023
|
Ann Powell EVP, Chief Human Resources |
BUY
Other acquisition or disposition
|
Direct |
5,174
+2.61%
|
-
|
|
Mar 10
2023
|
Ann Powell EVP, Chief Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
34,447
+13.86%
|
-
|
|
Mar 10
2023
|
Samit Hirawat EVP,Chief Med.Offr.,Drug Dev. |
SELL
Payment of exercise price or tax liability
|
Direct |
22,395
-13.21%
|
$1,455,675
$65.71 P/Share
|
|
Mar 10
2023
|
Samit Hirawat EVP,Chief Med.Offr.,Drug Dev. |
BUY
Other acquisition or disposition
|
Direct |
4,800
+2.78%
|
-
|
|
Mar 10
2023
|
Samit Hirawat EVP,Chief Med.Offr.,Drug Dev. |
BUY
Exercise of conversion of derivative security
|
Direct |
38,978
+18.42%
|
-
|
|
Mar 10
2023
|
Karin Shanahan EVP, Glob. Prod. Dev. & Supply |
SELL
Payment of exercise price or tax liability
|
Direct |
914
-36.18%
|
$59,410
$65.71 P/Share
|
|
Mar 10
2023
|
Karin Shanahan EVP, Glob. Prod. Dev. & Supply |
BUY
Other acquisition or disposition
|
Direct |
79
+3.03%
|
-
|
|
Mar 10
2023
|
Karin Shanahan EVP, Glob. Prod. Dev. & Supply |
BUY
Exercise of conversion of derivative security
|
Direct |
2,447
+50.0%
|
-
|
|
Mar 10
2023
|
Giovanni Caforio Executive Chair of the Board |
SELL
Payment of exercise price or tax liability
|
Direct |
137,989
-7.63%
|
$8,969,285
$65.71 P/Share
|
|
Mar 10
2023
|
Giovanni Caforio Executive Chair of the Board |
BUY
Other acquisition or disposition
|
Direct |
35,144
+2.0%
|
-
|
|
Mar 10
2023
|
Giovanni Caforio Executive Chair of the Board |
BUY
Exercise of conversion of derivative security
|
Direct |
234,676
+11.1%
|
-
|
|
Mar 10
2023
|
David V Elkins EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
41,331
-6.11%
|
$2,686,515
$65.71 P/Share
|
|
Mar 10
2023
|
David V Elkins EVP, Chief Financial Officer |
BUY
Other acquisition or disposition
|
Direct |
8,930
+1.3%
|
-
|
|
Mar 10
2023
|
David V Elkins EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
71,871
+9.26%
|
-
|
|
Mar 10
2023
|
Christopher S. Boerner Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
34,620
-9.46%
|
$2,250,300
$65.71 P/Share
|
|
Mar 10
2023
|
Christopher S. Boerner Chief Executive Officer |
BUY
Other acquisition or disposition
|
Direct |
8,568
+2.42%
|
-
|
|
Mar 10
2023
|
Christopher S. Boerner Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
59,111
+13.54%
|
-
|
|
Mar 10
2023
|
Gregory Scott Meyers EVP, Chief Digital & Tech Off. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,243
-26.22%
|
$80,795
$65.71 P/Share
|
|
Mar 10
2023
|
Gregory Scott Meyers EVP, Chief Digital & Tech Off. |
BUY
Other acquisition or disposition
|
Direct |
92
+1.9%
|
-
|
|
Mar 10
2023
|
Gregory Scott Meyers EVP, Chief Digital & Tech Off. |
BUY
Exercise of conversion of derivative security
|
Direct |
2,836
+37.89%
|
-
|
|
Mar 10
2023
|
Michelle Weese EVP, Corporate Affairs |
SELL
Payment of exercise price or tax liability
|
Direct |
594
-20.89%
|
$38,610
$65.71 P/Share
|
|
Mar 10
2023
|
Michelle Weese EVP, Corporate Affairs |
BUY
Other acquisition or disposition
|
Direct |
51
+1.76%
|
-
|
|
Mar 10
2023
|
Michelle Weese EVP, Corporate Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
1,590
+36.28%
|
-
|
|
Feb 06
2023
|
Giovanni Caforio Executive Chair of the Board |
SELL
Open market or private sale
|
Direct |
240,000
-50.41%
|
$17,760,000
$74.65 P/Share
|
|
Feb 06
2023
|
Ann Powell EVP, Chief Human Resources |
SELL
Open market or private sale
|
Direct |
11,183
-32.67%
|
$827,542
$74.69 P/Share
|
|
Feb 01
2023
|
Gregory Scott Meyers EVP, Chief Digital & Tech Off. |
SELL
Payment of exercise price or tax liability
|
Direct |
731
-28.75%
|
$51,901
$71.23 P/Share
|
|
Feb 01
2023
|
Gregory Scott Meyers EVP, Chief Digital & Tech Off. |
BUY
Exercise of conversion of derivative security
|
Direct |
2,543
+50.0%
|
-
|